APA (7th ed.) Citation

S, S., R, A., A, R., M, Y., F, M., F, N., . . . R, G. (2025). CD8-positive lymphocyte infiltration as a marker of anti-tumor immune response in rectal cancer: Pre- and post-neoadjuvant radiotherapy comparison. Clinical and translational radiation oncology, 54, 101018. https://doi.org/10.1016/j.ctro.2025.101018

Chicago Style (17th ed.) Citation

S, Salarvand, Abyaneh R, Raee A, Yaghooti-Khorasani M, Mohammadjani F, Nili F, Aghili M, and Ghalehtaki R. "CD8-positive Lymphocyte Infiltration as a Marker of Anti-tumor Immune Response in Rectal Cancer: Pre- and Post-neoadjuvant Radiotherapy Comparison." Clinical and Translational Radiation Oncology 54 (2025): 101018. https://doi.org/10.1016/j.ctro.2025.101018.

MLA (9th ed.) Citation

S, Salarvand, et al. "CD8-positive Lymphocyte Infiltration as a Marker of Anti-tumor Immune Response in Rectal Cancer: Pre- and Post-neoadjuvant Radiotherapy Comparison." Clinical and Translational Radiation Oncology, vol. 54, 2025, p. 101018, https://doi.org/10.1016/j.ctro.2025.101018.